Entry Point Capital, LLC Delcath Systems, Inc. Put Options Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding DCTH
# of Institutions
79Shares Held
7.78MCall Options Held
198KPut Options Held
41.7K-
Vivo Capital, LLC Palo Alto, CA1.71MShares$27.2 Million3.93% of portfolio
-
Aigh Capital Management LLC Baltimore, MD1.39MShares$22.1 Million6.61% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.22MShares$19.5 Million0.0% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT801KShares$12.8 Million0.66% of portfolio
-
Gilder Gagnon Howe & CO LLC New York, NY612KShares$9.75 Million0.08% of portfolio
About DELCATH SYSTEMS, INC.
- Ticker DCTH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 8,597,680
- Market Cap $137M
- Description
- Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling syste...